Vicki A. Montgomery

775 citations

14 papers · 650 indexed · h-index 10

Co-authors: Theresa J. Smith Leonard A. Smith Peter Amersdorfer Michael Byrne James D. Marks Robert C. Blake David B. Powers Robert E. Sheridan
Topics: Botulinum Toxin and Related Neurological Disorders (11 papers)Neurological disorders and treatments (6 papers)Hereditary Neurological Disorders (6 papers)
Cited by: Neurology Cellular and Molecular Neuroscience Endocrinology
Journals: Proceedings of the National Academy of Sciences The Journal of Infectious Diseases Antimicrobial Agents and Chemotherapy
Partner nations: United States Italy

In The Last Decade

Vicki A. Montgomery

14 papers receiving 608 citations

Peers

Countries citing papers authored by Vicki A. Montgomery

Since Specialization

Citations

This map shows the geographic impact of Vicki A. Montgomery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki A. Montgomery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki A. Montgomery more than expected).

Fields of papers citing papers by Vicki A. Montgomery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki A. Montgomery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki A. Montgomery. The network helps show where Vicki A. Montgomery may publish in the future.

Co-authorship network of co-authors of Vicki A. Montgomery

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki A. Montgomery. A scholar is included among the top collaborators of Vicki A. Montgomery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki A. Montgomery. Vicki A. Montgomery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™) 2020 ·Vaccine ·Vicki A. Montgomery,(unknown),Leonard A. Smith,Robert Webb	2
2	A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A 2016 ·Bioorganic & Medicinal Chemistry Letters ·William A. Harrell,(unknown),(unknown),Vicki A. Montgomery,(unknown),(unknown),(unknown),(unknown),John H. Cardellina,Robert Webb,Leonard A. Smith	10
3	Ex vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors 2015 ·Toxicon ·Vicki A. Montgomery,S. Ashraf Ahmed,Mark A. Olson,Md Mizanur Rahman,Robert G. Stafford,(unknown),Leonard A. Smith	9
4	Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A 2012 ·ACS Medicinal Chemistry Letters ·John H. Cardellina,(unknown),Vicki A. Montgomery,(unknown),(unknown),Xin Hu,Ilja V. Khavrutskii,Gregory J. Tawa,Anders Wallqvist,James B. Gloer,(unknown),Ulrich Höller,(unknown),Biren K. Joshi,(unknown),Donald T. Wicklow,Leonard A. Smith	22
5	Diagnostic and Possible Therapeutic Application of a Monoclonal Antibody (14G8) Directed Against botulinum Type C Neurotoxin 2011 ·Hybridoma ·Vicki A. Montgomery,Leonard A. Smith	2
6	Separation of Betti Reaction Product Enantiomers: Absolute Configuration and Inhibition of Botulinum Neurotoxin A 2011 ·ACS Medicinal Chemistry Letters ·John H. Cardellina,(unknown),(unknown),(unknown),Vicki A. Montgomery,(unknown),(unknown),William Leister,Christopher A. LeClair,David J. Maloney,Daniele Padula,Gennaro Pescitelli,Ilja V. Khavrutskii,Xin Hu,Anders Wallqvist,Leonard A. Smith	6
7	Identification and Biochemical Characterization of Small-Molecule Inhibitors ofClostridium botulinumNeurotoxin Serotype A 2009 ·Antimicrobial Agents and Chemotherapy ·(unknown),Istvan Enyedy,Vicki A. Montgomery,(unknown),(unknown),Huiguo Lai,(unknown),David C.H. Yang,Leonard A. Smith	61
8	Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins 2007 ·Vaccine ·Robert Webb,Theresa J. Smith,Patrick M. Wright,Vicki A. Montgomery,Michael M. Meagher,Leonard A. Smith	52
9	Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey 2006 ·Toxicon ·James W. Boles,Michael W. West,Vicki A. Montgomery,Ralph F. Tammariello,M. Louise M. Pitt,Paul Gibbs,Leonard A. Smith,Ross D. LeClaire	32
10	Roads from vaccines to therapies 2004 ·Movement Disorders ·Leonard A. Smith,(unknown),Vicki A. Montgomery,Douglas Brown,Saif Ahmed,Theresa J. Smith	24
11	Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody 2002 ·Proceedings of the National Academy of Sciences ·(unknown),(unknown),David B. Powers,Peter Amersdorfer,Theresa J. Smith,Vicki A. Montgomery,Robert E. Sheridan,Robert C. Blake,Lewis J. Smith,James D. Marks	268
12	The immunogenicity in humans of a botulinum type F vaccine 1999 ·Vaccine ·Vicki A. Montgomery,Richard S. Makuch,J. Brown,(unknown)	18
13	Purification, Potency, and Efficacy of the Botulinum Neurotoxin Type A Binding Domain fromPichia pastorisas a Recombinant Vaccine Candidate 1998 ·Infection and Immunity ·Michael Byrne,Theresa J. Smith,Vicki A. Montgomery,Leonard A. Smith	108
14	Characteristics of Carbon Dioxide-Independent Cultures of Brucella Abortus Isolated from Cattle Vaccinated with Strain 19 1965 ·The Journal of Infectious Diseases ·Lisa M. Jones,Vicki A. Montgomery,J. B. Wilson	36

About Vicki A. Montgomery

Vicki A. Montgomery is a scholar working on Neurology, Endocrinology and Cellular and Molecular Neuroscience, having authored 14 papers that have together received 650 indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (11 papers), Neurological disorders and treatments (6 papers) and Hereditary Neurological Disorders (6 papers). The work is most often cited by research in Neurology (424 citations), Cellular and Molecular Neuroscience (256 citations) and Endocrinology (66 citations). Vicki A. Montgomery has collaborated with scholars based in United States and Italy. Frequent co-authors include Theresa J. Smith, Leonard A. Smith, Peter Amersdorfer, Michael Byrne, James D. Marks, Robert C. Blake, David B. Powers, Robert E. Sheridan, Lewis J. Smith and Lisa M. Jones. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact